CELC vs CGEM

Celcuity Inc. vs Cullinan Therapeutics, Inc. — Valuation Comparison 2026

CELC

Biotechnology
Celcuity Inc.
Quality
4.0
out of 10
Value Trap
30
LOW
Price
$130.91
Last close
Models
10/13
Active
VS

CGEM

Biotechnology
Cullinan Therapeutics, Inc.
Quality
4.4
out of 10
Value Trap
24
SAFE
Price
$15.36
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType CELC Fair ValueCELC Upside CGEM Fair ValueCGEM Upside
Bayesian DCF Intrinsic $38.89 -70.3% $4.78 -68.9%
Earnings Power Value Intrinsic $54.23 -55.2%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.19 -99.8% $1.71 -88.9%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CELC vs CGEM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CELC vs CGEM — Which Stock Is More Undervalued?

CGEM scores higher with a 4.4/10 quality rating vs CELC's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Celcuity Inc. (CELC) and Cullinan Therapeutics, Inc. (CGEM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CELC currently trades at $130.91 with a QOC of 4.0/10, while CGEM trades at $15.36 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).